Effect of Prolactin on Lymphocyte Activation from Systemic Lupus Erythematosus Patients

:  The aim was to explore the role of prolactin (PRL) in the lymphocyte activation process in systemic lupus erythematosus (SLE) patients in an in vitro model. Peripheral blood mononuclear cells (PBMCs) were isolated from SLE patients and healthy individuals. The mRNA for PRL and its receptor obtain...

Full description

Saved in:
Bibliographic Details
Published in:Annals of the New York Academy of Sciences 2007-06, Vol.1108 (1), p.157-165
Main Authors: CHAVEZ-RUEDA, KARINA, LEGORRETA-HAQUET, VICTORIA MA, CERVERA-CASTILLO, HERNANDO, SÁNCHEZ, LOURDES, JARA, LUIS JAVIER, ZENTENO, EDGAR, CHAVEZ-SANCHEZ, LUIS, BLANCO-FAVELA, FRANCISCO
Format: Article
Language:English
Subjects:
Adult
Antigens, CD - metabolism
Antigens, Differentiation, T-Lymphocyte - metabolism
CD40 Ligand - metabolism
Cells, Cultured
Female
Flow Cytometry
Humans
Hyperprolactinemia - complications
Lectins, C-Type
Lupus Erythematosus, Systemic - complications
Lupus Erythematosus, Systemic - immunology
Lupus Erythematosus, Systemic - metabolism
Lymphocyte Activation - physiology
Lymphocytes - metabolism
prolactin
Prolactin - metabolism
Reverse Transcriptase Polymerase Chain Reaction
RNA, Messenger - analysis
SLE
T cell activation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary::  The aim was to explore the role of prolactin (PRL) in the lymphocyte activation process in systemic lupus erythematosus (SLE) patients in an in vitro model. Peripheral blood mononuclear cells (PBMCs) were isolated from SLE patients and healthy individuals. The mRNA for PRL and its receptor obtained by standard techniques, with an appropriate primer, were subjected to polymerase chain reaction (PCR) and visualized. The PBMCs were cultured with (a) medium alone as a negative control, (b) unspecific mitogen as a positive control, (c) PRL alone, (d) mitogen plus PRL, (e) mitogen plus antibody anti‐PRL, and (f) mitogen plus a nonrelated antibody. Then CD69 and CD154 were determined by flow cytometry analysis. Twelve inactive and 15 active SLE patients were studied. Twenty‐five percent of the active patients displayed hyperprolactinemia. Under basal conditions CD69 expression was associated with disease activity. The PBMCs activated in vitro were capable of producing and secreting PRL, measured by mRNA and Nb2 assay. In a similar way, the mRNA for the PRL receptor was visualized. Cells from SLE patients cultivated with PRL alone did not display increased CD69 and CD154 expression. The addition of PRL to the unspecific stimulated culture does not have an additive effect. In contrast, the addition of antibodies against PRL in order to block the autocrine PRL resulted in a striking reduction of CD69 and CD154 expression.
ISSN:0077-8923
1749-6632
1930-6547
DOI:10.1196/annals.1422.018